Ann Arbor, Michigan, US, and London, UK – NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its plasmacervical14 and plasmastomach14 multiplex protein assays, targeting cervical and stomach cancer biomarker discovery and qualification. The assays each measure 14 human plasma […]
Lexington, MA – T2 Biosystems, Inc., a company developing nextgeneration diagnostic products to improve clinical care, today announced that a panel of leading infectious disease and critical care experts have joined the company’s newly formed Clinical Advisory Board (CAB). The T2 Biosystems CAB members will help prioritize and support the development of the company’s pipeline […]
Cambridge, UK and Greenville, SC, USA, May 23rd – Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics has today announced that it has acquired Myconostica Ltd, a molecular diagnostic company focussing on the diagnosis of fungal infections of clinical importance. The financial terms of the deal were not disclosed. The acquisition of […]
BOZEMAN, Mont. & HOUSTON – Though two of the best-known methods for analyzing rare variants in sequencing data were published in 2008 and 2010, they have never been available to the public as a supported package. Baylor College of Medicine and Golden Helix announce the availability of the Combined Multivariate and Collapsing (CMC) and the […]
Marcy l’Etoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, has signed an agreement to acquire AES Laboratoire, a leading French group, specialized in industrial microbiological control, for 183 million euros. This will be bioMérieux’s ninth acquisition in five years and its third in the area of industrial applications. Founded […]
LOUISVILLE, K.Y. – Laboratory Supply Company (LABSCO), the largest privately held supplier of diagnostic instrumentation and clinical laboratory products to hospitals, physician office laboratories, reference labs and other non-acute care settings in the United States, announced today it has entered into an agreement with Cepheid (NASDAQ: CPHD) to become Cepheid’s exclusive distribution partner for its […]
European private equity firm, Cinven, today announces that it has reached an agreement to sell Phadia Group (“the Company”), the leading in-vitro allergy diagnostics company based in Uppsala (Sweden), to Thermo Fisher Scientific Inc. (NYSE: TMO) for an enterprise value of €2.47 billion. Having identified the diagnostic testing sector as a segment with strong growth […]
WALTHAM, Mass. & UPPSALA, Sweden – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to acquire Phadia, a global leader in allergy and autoimmunity diagnostics, from European private equity firm Cinven, for EUR2.47 billion (or approximately $3.5 billion) in cash. The transaction, […]
BALTIMORE – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the U.S. launch of the BD MAX™ for use as an open system. BD MAX is the first and only fully automated, bench-top molecular system designed to perform a broad range of molecular tests. This includes in vitro diagnostic […]
SUNNYVALE, Calif. – Cepheid (NASDAQ: CPHD) today announced it has entered into an agreement with LABSCO (www.labsco.com), the largest privately held distributor of clinical products in the United States, to become its US distribution partner for Cepheid’s GeneXpert? Systems and tests. The agreement grants LABSCO exclusive US distribution rights to the acute care hospital market […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
